The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
New Bull Market? Lock in those Gains…
We haven’t talked about selling stocks at a gain for quite some time. And we all know the reason why – there haven’t been many to talk about. But that doesn’t mean that there aren’t any. In fact, the markets have been up over the last week.
For many who have become comfortable with their bear market portfolio, prepare to be unnerved.
The companies many investors have used as defensive plays have performed very well – compared to the rest of the market. But that doesn’t mean that these stocks will continue to move that way. If we have a new bull, things will change. And fast.
Traders like to use the word “overbought” to describe when, in their opinion, a stock has risen too fast or is overextended. Any company can become overbought, even in a bear market. The danger here is that with a new bull market, there is a very good chance that the darlings of the bear will become victims of the bull.
You’ll start hearing overbought being used to describe companies like Dollar Tree (Nasdaq: DLTR) Family Dollar Stores (NYSE: FDO) and Big Lots (NYSE: BIG). These are companies have seen investors rushing in because they were “defensive.” As soon as they start looking for “growth” again, these stocks could come crashing down.
Last week should be a wake up call – the market can start moving, and fast without warning. What’s an investor to do? Two things.
First, it may be time for an early portfolio rebalancing. Start moving money from asset classes and stocks that have done well to others. Second, use an aggressive trailing stop strategy. It’s what we use, because it’s one of the best ways to protect your gains.
Companies mentioned in this article: DLTR, FDO and BIG.
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
![]() |
![]() |











Investment U RSS Feed